A desire to improve the techniques available to purify chemical components of mixtures led Mosbach to molecular imprinting. He had been working on affinity chromatography, a technique in which researchers pack a long tube, or column, with a material that binds preferentially to a particular compound. When a solution is forced through the column, the compound of interest sticks to the material, and unwanted substances flow out the far end. Later, the desirable compound can be washed from the packing material and collected as it streams out of the column.
Mosbach took this technique a step further by attaching enzymes to little polymer beads, which he then used as column-packing material. The bound enzymes promoted reactions among chemicals in the solutions passing through.
This provided a practical way for pharmaceutical companies to make large batches of drugs. Instead of using "the power of microorganisms" in bacterial cultures or yeast fermentations to change steroids like cortisone into drugs like prednisone, Mosbach says, the companies "could add a steroid to one end of the column and get product at the other end."
Eventually, Mosbach and his group decided to make the method more reliable under different conditions by bypassing enzymes altogether. By creating tiny cavities in a polymer, or plastic, that mimic the active sites of enzymes, the team essentially produces artificial March 18, 2000 Vol. 157 No. 12 p. 186 Copyright ©2000 by Science Service
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The self-assembly method for making molecularly imprinted polymers is simple and versatile. First, polymer building blocks, or monomers, bind to target molecules (white) in solution. Then, the monomers crosslink to form a rigid polymer. Finally, researchers chemically extract the target molecule to leave cavities of a specific shape and size.
An overall pattern of molecular imprints on a polymer sphere, 20 micrometers in diameter. Researchers have succeeded in creating dozens of these polymers. Mosbach and his colleagues manufacture the catalytic plastics via a method called self-assembly (SN: 3/1/97, p. S14). For a given target molecule, they choose a variety of simple chemical units, or monomers, that they predict will interact with the functional groups on the target. For example, if the target has positively charged groups, then negatively charged monomers go into the mix. If it has groups that will form hydrogen bonds, then the researchers choose other monomers that can complete those bonds.
When mixed together, the monomers surround the target molecules in a specific arrangement dictated by properties of both components and their interactions. The scientists then add crosslinking polymers that solidify the material into a rigid gel. Finally, the researchers wash out the original target molecules, which leave their imprints in the plastic.
These precisely shaped imprints are "cavities with antifunctionality-like the active site of an enzyme," Mosbach notes.
One of his group's current projects is to develop plastizymes that can degrade toxic compounds.
Kenneth J. Shea of the University of California, Irvine compares this imprinting to making a plaster mold of someone's right hand. Not only does the final cast perfectly fit just one person's hand, but it matches the right hand and not the left.
The comparison is apt because Shea and his team are developing imprinted polymers for separating so-called chiral compounds. Like a pair of hands, chiral molecules of a compound are mirror-image versions of each other. Separating these closely related forms is difficult to do chemically.
In some cases, drugs come in chiral forms that have very different properties-one may be therapeutic while the other causes disastrous side effects. Shea and his colleagues have used imprinted polymers to separate chiral forms of benzodiazepines, a class of drugs that serve as sedatives and muscle relaxants. They report their latest findings in the Jan. 26 JOURNAL OF THE AMERICAN CHEMICAL SOCIETY.
The imprints act like the natural benzodiazepine receptors, which are made of protein. The plastic versions are "somewhat primitive compared to the best protein recognition sites, but they're manmade," Shea says. "The material is more robust, unlike proteins, which are sensitive to pH, heat, et cetera. You can put the polymers on a hot plate and not lose recognition sites."
This hardiness makes imprinted polymers good for screening large numbers of compounds. As part of their strategy to select new drugs, pharmaceutical companies test thousands of chemicals to select the few that bind to a particular receptor and thus stimulate or block a biological effect.
Acting as artificial receptors, imprinted polymers could also work as sensors. For example, in one project Shea's group is making polymers to detect brevetoxin, a fish-killing compound produced by the algae that create red tides (SN: 9/27/97, p. 202). "It doesn't respond to conventional assays," Shea says, so samples have to be shipped to distant specialized laboratories for chemical identification.
His vision is to be able to detect brevetoxin with a method as simple as a home pregnancy test. A strip coated with a molecularly imprinted polymer and a fluorescent dye could serve as an on-the-spot indicator. Dip the strip in the water, and if it lights up, then the toxin is present.
Shea and his colleagues have also crafted molecularly imprinted polymers into films that act as semipermeable membranes. Like natural cell membranes, the polymer films let certain substances pass through but blocks others. The researchers found that their polymers could distin- March 18, 2000 Vol. 157 No. 12 p. 186 guish between very similar compounds. One film that they made permits adenine-one of the four bases that carries the code in DNA molecules-to pass through but blocks the other three bases.
The ability of imprinted polymers to mimic the human body's receptors isn't lost on materials scientist Buddy D. Ratner of the University of Washington in Seattle. He and his colleagues are creating imprinted polymers for biomedical implants.
"The materials that are in wide use in medicine, as far as the body is concerned, [are] all foreign materials," Ratner says. The body has a way of dealing with those interlopers: "It puts a wall around them," he explains, and keeps up a low level of inflammation.
Ratner predicts that molecularly imprinted materials could be integrated into a person's body instead of being isolated from it. He and a team of biologists, engineers, and materials scientists are trying to identify molecules that contribute to wound healing.
An implant made of an imprinted polymer could attract proteins that would encourage the body to integrate the implant with the natural tissue. The group demonstrated that artificial receptors for large proteins could indeed be imprinted into a polymer. They have successfully created pores for bovine serum albumin, immunoglobulin G, and fibrinogen, which are typical of proteins that mediate the body's response to foreign objects.
Companies use catalysts to speed many chemical processes. To use molecular imprinting, they would need imprinted materials that are tougher than polymers because reactions often take place under high temperatures and harsh conditions. Alexander Katz of the University of California, Berkeley and Mark E. Davis of the California Institute of Technology in Pasadena have extended the imprinting technique to silica, the main component of glass.
To the naked eye, imprinted silica looks the same as an ordinary piece of glass, says Katz. In the Jan. 20 NATURE, he and Davis describe their imprinting process, which constructs a silica network around the template molecules by the sol-gel method, in which the researchers apply a solution of silicon compounds and let the solvent evaporate (SN: 1/25/97, p. 56).
Their study broke new ground on two fronts, says Katz. They measured the number and size of the cavities available to bind the target molecules. "This is the first time in the history of the imprinting field that we can directly measure the pore volume of the material," says Katz.
Also, because the material is inorganic, the researchers can use nuclear magnetic resonance spectroscopy to track the binding of organic molecules. A polymer would create so much background noise that the molecules would be impossible to see using that technique. These advances will help researchers characterize the imprinted materials, he says.
"We hope to learn from biological systems to make catalysts that nature never had the need to make," says Katz.
Research into imprinted materials is still in its early stages. Scientists have some critical issues to resolve before the materials can become practical.
For one, they will have to increase the density of sites on the polymers, says Shea. Because the polymers have to be rigid, a lot of the volume is taken up by crosslinkers that connect the floppy molecules together.
The low concentration of sites is also due to the imperfect synthesis method. They "just throw it all together, and let 'er rip," Shea notes. This approach creates many good recognition sites, but also a fair number of bad ones.
Molecularly imprinted materials have a long way to go to rival natural proteins, which arrived at their present design through millions of years of evolution. A one-step polymer or sol-gel synthesis can't capture all of the subtleties of an enzyme or antibody. Scientists, though, are giving it their best shot. s s March 18, 2000 Vol. 157 No. 12 p. 186 
